Informations générales (source: ClinicalTrials.gov)

NCT04405726 Statut inconnu
Study of Clinical, Biological and Genetic Prognostic Factors of SARS-CoV-2 Infection in Patients Admitted in the Strasbourg University Hospitals (Covid-HUS)
Observational
  • Infection
University Hospital, Strasbourg, France (Voir sur ClinicalTrials)
mars 2020
mars 2022
29 juin 2024
COVID-19 is an emerging disease, for which no specific treatment options are currently available. Since the end of February 2020, and due to a SARS-CoV-2 superspreading event (religious meeting), the Strasbourg University Hospital (HUS) had faced a sudden increase of the number of COVID-19-positive patients in serious condition requiring hospitalization. At the same time, many people develop only mild or moderate symptoms. To date, the prognostic factors for the course of SARS-CoV-2 infection are unknown. The primary purpose of the "COVID-HUS" protocol is to investigate viral and host-related factors to understand the pathophysiology of COVID infection and to open the way for new diagnostic, prognostic and therapeutic strategies against SARS CoV-2 . The secondary objectives are - Monitoring of viral replication of SARS-CoV-2 in the blood and respiratory tract in infected patients - Monitoring of the humoral and cellular response directed against SARS-CoV-2 - Identification of factors leading to significant and / or prolonged viral replication of SARS-CoV-2 in the blood or respiratory samples - Evaluation of the benefit of possible treatments implemented following the diagnosis of SARS-CoV-2 infection - Exploration of the B and T immune repertoire sequences targeting SARS-CoV-2 in infected patients - Typing of the HLA system in infected patients

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Service de Virologie - Hôpital Civil - 67091 - Strasbourg - France Samira FAFI-KREMER, PharmD, PhD En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Adult and pediatric with suspicion or a confirmed SARS-CoV-2 infection

- Patient who has signed a non-opposition form (or a form signed by a family member or
a support person if the seriousness of the patient's condition and the emergency
situation do not allow it) or who has given his oral agreement to the doctor



- Patient's explicit refusal to participate

- Subject deprived of liberty or subject to the protection of justice

- Subject under guardianship or trusteeship